Validation of RDQ questionnaire
Study identifier:D9914C00002
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A single-blind single arm study to validate the Reflux Disease Questionnaire (RDQ) for the diagnosis of reflux disease in primary care in patients treated with esomeprazole 40 mg o.d.
Medical condition
Gastroesophageal Reflux
Phase
Phase 4
Healthy volunteers
No
Study drug
Esomeprazole
Sex
All
Actual Enrollment
350
Study type
Interventional
Age
18 Years - 79 Years
Date
Study Start Date: 01 Sept 2005
Primary Completion Date: -
Study Completion Date: 01 Nov 2006
Study design
Allocation: Non-randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Single Blind
Primary Purpose: Diagnostic
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
Contacts
Investigators
Principal Investigator
AstraZeneca Nexium Medical Science Director
AstraZeneca
